These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12907264)

  • 1. Analysis for residual host cell proteins and DNA in process streams of a recombinant protein product expressed in Escherichia coli cells.
    Rathore AS; Sobacke SE; Kocot TJ; Morgan DR; Dufield RL; Mozier NM
    J Pharm Biomed Anal; 2003 Aug; 32(6):1199-211. PubMed ID: 12907264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel multimodal chromatography based single step purification process for efficient manufacturing of an E. coli based biotherapeutic protein product.
    Bhambure R; Gupta D; Rathore AS
    J Chromatogr A; 2013 Nov; 1314():188-98. PubMed ID: 24063981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
    Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
    Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High pressure homogenization is a key unit operation in inclusion body processing.
    Eggenreich B; Wurm DJ; Rajamanickam V; Klausser R; Slouka C; Spadiut O
    J Biotechnol; 2020; 324S():100022. PubMed ID: 34154734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host cell protein testing by ELISAs and the use of orthogonal methods.
    Zhu-Shimoni J; Yu C; Nishihara J; Wong RM; Gunawan F; Lin M; Krawitz D; Liu P; Sandoval W; Vanderlaan M
    Biotechnol Bioeng; 2014 Dec; 111(12):2367-79. PubMed ID: 24995961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
    Wang C; Wang L; Geng X
    Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.
    Ehgartner D; Sagmeister P; Langemann T; Meitz A; Lubitz W; Herwig C
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5603-5614. PubMed ID: 28429059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA.
    Gunawan F; Nishihara J; Liu P; Sandoval W; Vanderlaan M; Zhang H; Krawitz D
    Biotechnol Bioeng; 2018 Feb; 115(2):382-389. PubMed ID: 28986978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host cell protein testing strategy for hepatitis B antigen in Hexavalent vaccine - Towards a general testing strategy for recombinant vaccines.
    Toinon A; Fontaine C; Thion L; Gajewska B; Carpick B; Nougarede N; Uhlrich S
    Biologicals; 2018 Jul; 54():1-7. PubMed ID: 29861269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the efficacy of immobilized metal affinity chromatography (IMAC) for host cell protein (HCP) removal from anti-HER2 scFv expressed in Escherichia coli.
    Soltaninasab S; Ahmadzadeh M; Shahhosseini S; Mohit E
    Protein Expr Purif; 2022 Feb; 190():106004. PubMed ID: 34688918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Pressure Homogenization for Inclusion Body Isolation.
    Ebner J; Sedlmayr V; Klausser R
    Methods Mol Biol; 2023; 2617():141-154. PubMed ID: 36656521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.
    Bracewell DG; Francis R; Smales CM
    Biotechnol Bioeng; 2015 Sep; 112(9):1727-37. PubMed ID: 25998019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell protein analysis in therapeutic protein bioprocessing - methods and applications.
    Tscheliessnig AL; Konrath J; Bates R; Jungbauer A
    Biotechnol J; 2013 Jun; 8(6):655-70. PubMed ID: 23436780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
    Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
    Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
    Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
    Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel aqueous two phase assisted platform for efficient removal of process related impurities associated with E. coli based biotherapeutic protein products.
    Bhambure R; Sharma R; Gupta D; Rathore AS
    J Chromatogr A; 2013 Sep; 1307():49-57. PubMed ID: 23921264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring process-related impurities in biologics-host cell protein analysis.
    Pilely K; Johansen MR; Lund RR; Kofoed T; Jørgensen TK; Skriver L; Mørtz E
    Anal Bioanal Chem; 2022 Jan; 414(2):747-758. PubMed ID: 34595561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF1 inclusion bodies: A QbD based process approach for efficient USP as well as early DSP unit operations.
    Metzger KFJ; Padutsch W; Pekarsky A; Kopp J; Voloshin AM; Kühnel H; Maurer M
    J Biotechnol; 2020 Mar; 312():23-34. PubMed ID: 32114153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
    Krachmarova E; Ivanov I; Nacheva G
    Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.